The characteristics of patients with multiple myeloma surviving over 10 years
Being younger, having a neutrophil count above 3.66 * 10<sup>9</sup>/L, the absence of high-risk cytogenetic abnormalities, and receiving frontline ASCT are independent protective factors for transplant-eligible MM patients to survive more than 10 years. Achieving maintained MRD negativity status for over 24 months might be associated with long-term survival.
Authors
- Lifen Kuang
- Beihui Huang (ORCID: https://orcid.org/0000-0003-2804-4913)
- Juan Li (ORCID: https://orcid.org/0000-0002-2140-1845)
- Jingli Gu (ORCID: https://orcid.org/0000-0001-5574-649X)
- Junru Liu (ORCID: https://orcid.org/0000-0001-6462-3547)
- Xiaozhe Li (ORCID: https://orcid.org/0009-0003-1903-3849)
- Mei-Lan Chen (ORCID: https://orcid.org/0000-0002-0461-1066)
- Hongning Zhang
Institutions
- Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3389/fonc.2024.1490630
- Citations
- 2
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.91
Funders
- National Natural Science Foundation of China